These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1279310)

  • 21. Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias.
    Helmy I; Herre JM; Gee G; Sharkey H; Malone P; Sauve MJ; Griffin JC; Scheinman MM
    J Am Coll Cardiol; 1988 Oct; 12(4):1015-22. PubMed ID: 3417974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amiodarone in refractory life-threatening ventricular arrhythmias.
    Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
    Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of electrophysiologic testing in the treatment of drug-refractory ventricular arrhythmias with amiodarone.
    Borggrefe M; Breithardt G
    Eur Heart J; 1986 Sep; 7(9):735-42. PubMed ID: 3769956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of oral amiodarone in the treatment of ventricular arrhythmias in heart disease.
    Levy S
    Drugs; 1991; 41 Suppl 2():47-53. PubMed ID: 1711968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of ventricular arrhythmia after corrective cardiac surgery in a neonate with intravenous amiodarone.
    Bogers AJ; Quaegebeur JM; Ottenkamp J; Huysmans HA
    Thorac Cardiovasc Surg; 1987 Apr; 35(2):124-5. PubMed ID: 2440134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of electrophysiologic study to determine the clinical tolerance of arrhythmia recurrences during amiodarone therapy.
    Kadish AH; Buxton AE; Waxman HL; Flores B; Josephson ME; Marchlinski FE
    J Am Coll Cardiol; 1987 Jul; 10(1):90-6. PubMed ID: 3598000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiodarone in long term prophylaxis.
    Katritsis D; Camm AJ
    Drugs; 1991; 41 Suppl 2():54-66. PubMed ID: 1711969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial).
    Janse MJ; Malik M; Camm AJ; Julian DG; Frangin GA; Schwartz PJ
    Eur Heart J; 1998 Jan; 19(1):85-95. PubMed ID: 9503180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial.
    Hamer AW; Arkles LB; Johns JA
    J Am Coll Cardiol; 1989 Dec; 14(7):1768-74. PubMed ID: 2685081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction.
    Pfisterer ME; Kiowski W; Brunner H; Burckhardt D; Burkart F
    Circulation; 1993 Feb; 87(2):309-11. PubMed ID: 8425280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Does amiodarone have a benefit effect on mortality?].
    Pathé M; Kahn JC
    Presse Med; 1991 Sep; 20(28):1330-4. PubMed ID: 1833737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure.
    Cleland JG; Dargie HJ; Findlay IN; Wilson JT
    Br Heart J; 1987 May; 57(5):436-45. PubMed ID: 3297121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelin-1 gene polymorphism in patients with malignant arrhythmias.
    Kozák M; Izákovicová Hollá L; Krivan L; Vasků A; Sepsi M; Semrád B; Vácha J
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S92-5. PubMed ID: 15838369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.
    Gill J; Heel RC; Fitton A
    Drugs; 1992 Jan; 43(1):69-110. PubMed ID: 1372862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the efficacy of propranolol and amiodarone in suppressing ventricular arrhythmias following myocardial infarction.
    Fournier C; Brunet M; Bah M; Kindermans M; Boujon B; Tournadre P; Giudicelli JF; Blondeau M
    Eur Heart J; 1989 Dec; 10(12):1090-100. PubMed ID: 2691252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac function in patients on chronic amiodarone therapy.
    Ellenbogen KA; O'Callaghan WG; Colavita PG; Smith MS; German LD
    Am Heart J; 1985 Aug; 110(2):376-81. PubMed ID: 4025113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amiodarone for recurring ventricular arrhythmias: assessment by 24-hour Holter ambulatory electrocardiography.
    Hwang YS
    Taiwan Yi Xue Hui Za Zhi; 1986 Aug; 85(8):790-8. PubMed ID: 3467021
    [No Abstract]   [Full Text] [Related]  

  • 38. Amiodarone for arrhythmia in patients with Chagas disease: A systematic review and individual patient data meta-analysis.
    Stein C; Migliavaca CB; Colpani V; da Rosa PR; Sganzerla D; Giordani NE; Miguel SRPS; Cruz LN; Polanczyk CA; Ribeiro ALP; Falavigna M
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006742. PubMed ID: 30125291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiodarone therapy guided by electrophysiologic testing: an update.
    Somberg J; Kreamer J; Camba N
    J Clin Pharmacol; 1991 Nov; 31(11):1089-95. PubMed ID: 1753014
    [No Abstract]   [Full Text] [Related]  

  • 40. Amiodarone in patients with heart failure.
    Breithardt G
    N Engl J Med; 1995 Jul; 333(2):121-2. PubMed ID: 7777017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.